Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
Volume 0.40M
Average 0.51M
AVLN Interest Income
Income earned on cash, deposits, and investments held by the company.
Interest Income history
Currency unavailable · from the income statement
No Interest Income data reported for this period type.
Interest Income vs competitors
How AVLN compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $45.57M USD | -25.8% | +76.2% | 4.0% | |
VCREVicore Pharma Holding AB | LTM Jun 2026 | SEK 21.37M SEK | +23.9% | +196.9% | 1607.1% |
| LTM Mar 2026 | $9.68M USD | -13.1% | — | 2.7% | |
| LTM Mar 2026 | $1.01M USD | -28.9% | +34.0% | 0.9% | |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding AVLN) | — | -19.4% | +76.2% | 3.3% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.